Globe Life stock trades near recent highs as earnings and capital returns support valuation

Globe Life Inc. (ISIN US37959E1029) is drawing renewed attention from investors as Globe Life stock trades near recent highs on the New York Stock Exchange, supported by growing insurance premiums, steady earnings and continued capital returns to shareholders as reported in the companys latest filings and investor materials in 2024.

Premium growth underpins revenue in 2024

According to Globe Lifes 2024 quarterly and annual disclosures available via its investor relations page, total life insurance premium at the company increased in fiscal 2023 compared with fiscal 2022, reflecting both new business and persistency in in-force policies, and this trend continued into the first half of 2024 as management highlighted higher premiums in the life and supplemental health segments based on its reported figures for those periods.

The companys filings for fiscal 2023 show that Globe Life generated net income attributable to common shareholders in the billions of dollars range, with earnings per share rising compared with the prior year, and in 2024 interim reports the insurer has indicated continued growth in net operating income per share, even as higher interest rates and claims trends shape the broader insurance environment, giving investors a set of concrete earnings metrics to analyze when assessing Globe Life stock.

Globe Life has also emphasized in its investor presentations that underwriting margins in key segments remain within targeted ranges, with benefits ratios for certain lines improving versus prior-year periods, illustrating how managements focus on disciplined underwriting and expense control translates into tangible operating results that can support a sustained valuation multiple on the shares.

Dividend and share repurchases support total return

In addition to earnings growth, Globe Lifes capital return program is a central element of the investment case for Globe Life stock, as the company continues to pay a regular cash dividend and execute share repurchases under its authorized buyback plan based on disclosures in its recent annual report and quarterly updates.

For fiscal 2023, Globe Life reported paying hundreds of millions of dollars in cash dividends to common shareholders, and the boards dividend policy has delivered a recurring per-share payout that has been maintained or modestly increased over time according to the historical dividend data in the companys filings, offering investors an income stream alongside the potential for capital gains.

Globe Lifes management has also disclosed that the company repurchased a significant number of its own shares in 2023 and continued buybacks into 2024, reducing the weighted average diluted share count compared with prior-year levels, and this share reduction works in tandem with earnings growth to lift earnings per share and support the insurers ability to grow per-share metrics even when headline net income growth is moderate.

Life and health products drive the business

At an operational level, Globe Lifes core business consists of life insurance and supplemental health insurance products that target middle-income households and individuals across the United States, and these products provide the premium base that underpins the companys revenue and earnings profile.

Company materials describe how Globe Life distributes its policies primarily through exclusive agencies and direct-to-consumer channels, focusing on relatively simple, individually underwritten products that can generate stable underwriting results and predictable cash flows, which in turn give management confidence to maintain dividends and repurchases and help investors frame expectations for Globe Life stock over multi-year horizons.

Specific product lines, such as term life insurance, whole life insurance and supplemental health coverage including hospital and accident policies, have shown year-on-year premium growth in recent reporting periods according to the segments tables in Globe Lifes financials, and this segment expansion contributes directly to the increases in total premiums that the company has highlighted for 2023 and 2024.

Globe Life stock and current valuation context

On the market side, Globe Life stock trades on the New York Stock Exchange under the symbol GL, and recent quote data from major financial portals show the shares changing hands in the upper-hundreds-dollar range, with a market capitalization in the multi-billion-dollar band that places the insurer among the mid-sized constituents of major US financial indexes.

The shares have traded within a defined 52-week range over the past year, with a low in the mid-hundreds dollars and a high approaching the lower two-hundreds dollars based on price histories from standard quote services, and this range gives investors a reference frame for current levels as they compare the prevailing price with Globe Lifes historical valuation multiples on metrics such as price-to-earnings and price-to-book value.

Analyst consensus data compiled by financial platforms indicates that Globe Life currently carries an overall rating in the buy area, with an average target price moderately above recent trading levels and at least one analyst house assigning a stronger rating and a higher target, implying potential upside if the company delivers on its earnings and capital return plans and if the broader insurance sector remains supportive.